GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » PB Ratio

Covalon Technologies (TSXV:COV) PB Ratio : 1.52 (As of May. 11, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Covalon Technologies PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-11), Covalon Technologies's share price is C$1.09. Covalon Technologies's Book Value per Share for the quarter that ended in Dec. 2023 was C$0.72. Hence, Covalon Technologies's PB Ratio of today is 1.52.

The historical rank and industry rank for Covalon Technologies's PB Ratio or its related term are showing as below:

TSXV:COV' s PB Ratio Range Over the Past 10 Years
Min: 0.53   Med: 2.8   Max: 18.37
Current: 1.41

During the past 13 years, Covalon Technologies's highest PB Ratio was 18.37. The lowest was 0.53. And the median was 2.80.

TSXV:COV's PB Ratio is ranked better than
71.85% of 1311 companies
in the Biotechnology industry
Industry Median: 2.5 vs TSXV:COV: 1.41

During the past 12 months, Covalon Technologies's average Book Value Per Share Growth Rate was -23.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 29.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 12.20% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 10.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Covalon Technologies was 43.20% per year. The lowest was -35.80% per year. And the median was -2.80% per year.

Back to Basics: PB Ratio


Covalon Technologies PB Ratio Historical Data

The historical data trend for Covalon Technologies's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies PB Ratio Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.98 3.40 1.96 2.53 1.97

Covalon Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.51 2.56 2.07 1.97 1.48

Competitive Comparison of Covalon Technologies's PB Ratio

For the Biotechnology subindustry, Covalon Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's PB Ratio distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's PB Ratio falls into.



Covalon Technologies PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Covalon Technologies's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=1.09/0.716
=1.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Covalon Technologies  (TSXV:COV) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Covalon Technologies PB Ratio Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (TSXV:COV) Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.

Covalon Technologies (TSXV:COV) Headlines

No Headlines